Peer Review reports
From: Picropodophyllin (PPP) is a potent rhabdomyosarcoma growth inhibitor both in vitro and in vivo
Original Submission | ||
---|---|---|
8 Feb 2016 | Submitted | Original manuscript |
12 May 2016 | Reviewed | Reviewer Report - Dawn S. Chandler |
29 Sep 2016 | Reviewed | Reviewer Report - Vincenzo Tombolini |
10 Nov 2016 | Author responded | Author comments - Maciej Tarnowski |
Resubmission - Version 2 | ||
10 Nov 2016 | Submitted | Manuscript version 2 |
28 Nov 2016 | Reviewed | Reviewer Report - Dawn S. Chandler |
2 Mar 2017 | Author responded | Author comments - Maciej Tarnowski |
Resubmission - Version 3 | ||
2 Mar 2017 | Submitted | Manuscript version 3 |
12 Apr 2017 | Reviewed | Reviewer Report - Dawn S. Chandler |
19 Jun 2017 | Author responded | Author comments - Maciej Tarnowski |
Resubmission - Version 4 | ||
19 Jun 2017 | Submitted | Manuscript version 4 |
4 Jul 2017 | Author responded | Author comments - Maciej Tarnowski |
Resubmission - Version 5 | ||
4 Jul 2017 | Submitted | Manuscript version 5 |
13 Jul 2017 | Author responded | Author comments - Maciej Tarnowski |
Resubmission - Version 6 | ||
13 Jul 2017 | Submitted | Manuscript version 6 |
Publishing | ||
23 Jul 2017 | Editorially accepted | |
9 Aug 2017 | Article published | 10.1186/s12885-017-3495-y |
You can find further information about peer review here.